Objectives: Therapeutic drug monitoring (TDM) combines the quantification of drug concentrations
in blood, pharmacological interpretation and treatment guidance. TDM introduces a …

Rationale In psychiatric clinical practice, there is a need to identify psychotropic drugs whose
metabolisms are prone to be altered with increased inflammatory activity in an individual …

Covid-19 is a new coronavirus disease first described in December 2019. This respiratory
illness is severe and potentially fatal. Severe cases make up to 15%, lethality ranges between …

… The higher prevalence rate of 53.0% in the study by Hefner, compared with the prevalence
rate of 33.9… Furthermore, the small sample size in the study by Hefner should be considered. …

Purpose The aim of this study was to analyze the epidemiology of polypharmacy in hospital
psychiatry. Another aim was to investigate predictors of the number of drugs taken and the …

BACKGROUND Thrombotic thrombocytopenic purpura (TTP) is an acute life‐threatening
microangiopathy with a tendency of relapse characterized by consumptive thrombocytopenia, …

In the pathogenesis of Alzheimer’s disease (AD) the homeostasis of amyloid precursor
protein (APP) processing in the brain is impaired. The expression of the competing proteases …

… inhibitors, inducers and pharmacokinetic DDI were similar in the study by Hefner and in
this study. In the study by Hefner et al. from 2015 (Hefner et al. 2015 Jul.), moderate or strong …

Background: The use of therapeutic drug monitoring (TDM) to guide treatment with long-acting
injectable (LAI) antipsychotics, which are increasingly prescribed, remains a matter of …

Both inflammation and smoking can influence a drug’s pharmacokinetic properties, ie, its
liberation, absorption, distribution, metabolism, and elimination. Depending on, eg, …